From: Can pelvic diameter measurement have an effect on surgical outcomes in radical cystectomy?
Mean ± SD | Median (Min–Max) | |
---|---|---|
Age ( year) | 68.25 ± 9.71 | 69 (29–93) |
BMI ( kg/m2) | 25.96 ± 3.19 | 26.50 (19–35,1) |
Prostate volume (cc) | 47.94 ± 25.40 | 42 (20–168) |
HGB (g/dL) | 12.01 ± 1.58 | 12 (9–15.60) |
HCT (%) | 35.81 ± 4.60 | 35.60 (27–46.80) |
Creatinine (mg/dL) | 1.22 ± 0.53 | 1.10 (0.6–3.5) |
Albumin (g/L) | 3.52 ± 0.61 | 3.6 (2.3–4.5) |
Operation time (min) | 322 ± 76.96 | 320 (169–551) |
Hospital stay (day) | 11.93 ± 6.58 | 11 (4–49) |
Estimated blood loss (mL) | 1356.96 ± 514.88 | 1250 (500–3000) |
Pelvic Dimensions | ||
UC | 10.17 ± 0.79 | 10.14 (8.29–11.90) |
LC | 11.02 ± 0.89 | 11.20 (9.11–13.07) |
PD | 11.81 ± 0.85 | 11.80 (9.71–13.49) |
AD | 3.19 ± 0.40 | 3.12 (2.33–3.97) |
SA | 41.99 ± 5.36 | 41.09 (29.89–57.64) |
ISD | 8.93 ± 0.65 | 8.81 (7.33–10.60) |
BFW | 10.15 ± 0.53 | 10.09 (9.07–11.80) |
SW | 4.60 ± 0.36 | 4.63 (3.54–5.79) |
ISD index | 2.86 ± 0.41 | 2.85 (2.02–4.04) |
BFW index | 3.25 ± 0.44 | 3.21 (2.45–4.85) |
SW index | 1.47 ± 0.22 | 1.46 (1.03–2.33) |
n | % | |
ASA Score | ||
2 | 35 | 44.3 |
3 | 43 | 54.4 |
4 | 1 | 1.3 |
Charlson score | ||
< 5 | 54 | 68.4 |
≥ 5 | 25 | 31.6 |
Pathological stage | ||
pTa + PTcis | 10 | 12.7 |
pT1 | 4 | 5.1 |
pT2 | 22 | 27.8 |
pT3 | 24 | 30.4 |
pT4 | 17 | 21.5 |
Excluding TCC | 2 | 2.5 |
Lymph node | ||
N0 | 52 | 65.8 |
N1 | 17 | 21.5 |
N2 | 10 | 12.7 |
Clavien-Dindo classification | ||
Minor Complication (Grade 0–2) | 30 | 38 |
Major Complication (Grade 3–5) | 22 | 27.8 |
90-day mortality (Grade 5 complication) | 11 | 13.9 |
Prior abdominal surgery | 7 | 8.9 |
Perioperative complication | 8 | 10.1 |
Postoperative complication | 52 | 65.8 |
Perioperative transfusion | 25 | 31.6 |
Surgical margin positivity | 11 | 13.9 |